Collaboration over at least three years aims to help understand how pre-cancerous cells develop
Business live – latest updates
GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.
The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.
More Stories
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Amazon’s satellite launch designed to compete with Musk’s Starlink cancelled
Tesla stops taking orders in China for two models imported from US